COVID-19 and breast cancer: may the microbiome be the issue?

Angioletta Lasagna¹, Valentina Zuccaro², Elisa Ferraris¹, Marta Corbella³, Raffaele Bruno^{2

4}, Paolo Pedrazzoli^{1

5}

Affiliations

¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
² Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
³ Department of Microbiology & Virology, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
⁴ Department of Clinical Surgical Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, 27100, Pavia, Italy.
⁵ Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, 27100, Pavia, Italy.

Editorial

Angioletta Lasagna et al. Future Oncol. 2021 Jan.

. 2021 Jan;17(2):123-126.

doi: 10.2217/fon-2020-0764. Epub 2020 Nov 27.

Angioletta Lasagna¹, Valentina Zuccaro², Elisa Ferraris¹, Marta Corbella³, Raffaele Bruno^{2

4}, Paolo Pedrazzoli^{1

5}

¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
² Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
³ Department of Microbiology & Virology, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
⁴ Department of Clinical Surgical Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, 27100, Pavia, Italy.
⁵ Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, 27100, Pavia, Italy.

No abstract available

Keywords: COVID-19; SARS-CoV-2; X chromosome; breast cancer; estrobolome; estrogen; gut microbiota; microbiome.

References

1. Dai M, Liu D, Liu M. et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 10(6), 783–791 2020). - PMC - PubMed
1. Hoffmann M, Kleine-Weber H, Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2), 271–280e278 (2020). - PMC - PubMed
1. Wang B, Huang Y. Which type of cancer patients are more susceptible to the SARS-COX-2: evidence from a meta-analysis and bioinformatics analysis. Crit. Rev. Oncol. Hematol. 153, 103032 2020). - PMC - PubMed
1. Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J. Biol. Regul. Homeost. Agents 34(2), 339–343 (2020). - PubMed
2. • Explains how the activation levels of immune cells are higher in women than in men.
1. Kloc M, Ghobrial RM, Kubiak JZ. The role of genetic sex and mitochondria in response to COVID-19 infection. Int. Arch. Allergy Immunol. 181(8), 629–634 (2020). - PMC - PubMed